SCHEMBL304715

SCHEMBL304715

CCCCCCC[CH]c1cccc2ccccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHAT P28329 2/20 0.52
CNR1 P21554 3/20 0.51
GAA P10253 4/20 0.40
KDM4E B2RXH2 3/20 0.40
NPC1 O15118 3/20 0.40
ALDH1A1 P00352 3/20 0.40
HTT P42858 3/20 0.40
RAB9A P51151 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
NPSR1 Q6W5P4 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
HPGD P15428 1/20 0.40
CYP2C19 P33261 1/20 0.40
MAPK1 P28482 1/20 0.40
RAD52 P43351 1/20 0.40
CNR2 P34972 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL304710 1.00 CHAT (0.52) CHATCNR1GAAKDM4ENPC1
SCHEMBL304218 1.00 CHAT (0.52) CHATCNR1GAAKDM4ENPC1
SCHEMBL302714 1.00 CHAT (0.52) CHATCNR1GAAKDM4ENPC1
SCHEMBL302934 1.00 CHAT (0.52) CHATCNR1GAAKDM4ENPC1
SCHEMBL302668 1.00 CHAT (0.52) CHATCNR1GAAKDM4ENPC1
SCHEMBL303784 1.00 CHAT (0.52) CHATCNR1GAAKDM4ENPC1
SCHEMBL303905 1.00 CHAT (0.52) CHATCNR1GAAKDM4ENPC1
SCHEMBL303704 1.00 CHAT (0.52) CHATCNR1GAAKDM4ENPC1
SCHEMBL303925 1.00 CHAT (0.52) CHATCNR1GAAKDM4ENPC1
SCHEMBL302709 1.00 CHAT (0.52) CHATCNR1GAAKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116848094-A Tertiary amine lipid compounds and uses thereof 华南理工大学 2023-10-03 CN claimed
WO-2023125184-A1 TERTIARY AMINE LIPID COMPOUND AND USE THEREOF 华南理工大学 2023-07-06 WO claimed
CN-116848094-A Tertiary amine lipid compounds and uses thereof 华南理工大学 2023-10-03 CN disclosed
CN-110291675-B Solid electrolyte composition, solid electrolyte-containing sheet, all-solid-state secondary battery, and methods for producing both 富士胶片株式会社 2023-02-21 CN disclosed
CN-108290820-B Method for recovering aromatic alcohol from melt polymerization and system for recovering same 沙特基础工业全球技术有限公司 2021-10-01 CN disclosed
EP-3239111-B1 CURABLE COMPOSITION, TRANSFER FILM, FRONT PLATE OF IMAGE DISPLAY DEVICE, FRONT PLATE-INTEGRATED SENSOR, IMAGE DISPLAY DEVICE, AND MANUFACTURING METHOD FOR FRONT PLATE OF IMAGE DISPLAY DEVICE FUJIFILM CORP (JP) 2021-02-17 EP disclosed
CN-108026359-B Polyester composition and mobile electronic device parts made therefrom 索尔维特殊聚合物美国有限责任公司 2021-02-09 CN disclosed
CN-107849306-B Glass fiber reinforced PDMS copolycarbonate resin 沙特基础工业全球技术公司 2021-02-02 CN disclosed
CN-106660953-B High heat resistant monomers and methods of use thereof 沙特基础工业全球技术有限公司 2020-07-28 CN disclosed
CN-110655525-A 2-hydrocarbyl-3- (dihydroxyfluorescein) phthalimide monomers, methods of manufacture, and copolymers derived therefrom 沙特基础工业全球技术有限公司 2020-01-07 CN disclosed
US-10035927-B2 Coloring composition for decoration, decorative material, base material having decorative material, transfer material, touch panel, and information display device FUJIFILM CORPORATION (JP) 2018-07-31 US disclosed
EP-1707548-A1 METHOD OF DEUTERATION USING MIXED CATALYST Wako Pure Chemical Industries, Ltd. (JP) 2006-10-04 EP disclosed
US-20060116535-A1 Method of deuteration WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2006-06-01 US disclosed
US-20060025596-A1 Method for deuteration or tritiation of heterocyclic ring FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2006-02-02 US disclosed
EP-1577280-A1 METHOD OF DEUTERIZATION Wako Pure Chemical Industries, Ltd. (JP) 2005-09-21 EP disclosed
EP-1561741-A1 METHOD FOR DEUTERATION OR TRITIATION OF HETEROCYCLIC RING Wako Pure Chemical Industries, Ltd. (JP) 2005-08-10 EP disclosed
EP-1535889-A1 METHOD OF DEUTERATING AROMATIC RING Wako Pure Chemical Industries, Ltd. (JP) 2005-06-01 EP disclosed
CN-1198181-C Photoresist compositions comprising polycyclic polymers with acid labile pendant groups SUMITOMO BAKELITE CO (JP) 2005-04-20 CN disclosed
CN-1269810-A Photoresist compositions comprising polycyclic polymers with acid labile pendant groups GOODRICH CO B F (US) 2000-10-11 CN disclosed
CN-1185164-A Homopolymers and copolymers of cationically polymerizable monomers, and prepn. method therefor GOODRICH CO B F (US) 1998-06-17 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025596-A1 Method for deuteration or tritiation of heterocyclic ring HRH2, HRH4, HDHD5 CHAT 2924/4885CNR1 609/4885GAA 1409/4885
US-20060116535-A1 Method of deuteration ARL1, IDH2, IDH3A CHAT 4135/4885CNR1 1224/4885GAA 3103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.